Literature DB >> 17004016

Sequential screening for diabetes--evaluation of a campaign in Swiss community pharmacies.

Kurt E Hersberger1, Andrea Botomino, Maxime Mancini, Rudolf Bruppacher.   

Abstract

OBJECTIVE: For early detection of persons at risk for type 2 diabetes, a combination of risk factor assessment and glucose measurement could be a promising approach and an opportunity for health promotion. The object of this study was to develop a sequential screening concept and to evaluate it in a national pharmacy based screening campaign.
METHOD: Community pharmacies of the German speaking part of Switzerland participating in the national Self Care campaign "Stop diabetes--test now" offered a free of charge "sequential screening" with (a) diabetes risk assessment, (b) consecutive capillary blood glucose measurement and (c) assessment of the motivation for lifestyle change based on the Transtheoretical Model (TTM) of behaviour change. A 35 items data sheet served as a structured screening protocol and enabled quick and reliable documentation of all relevant data. Outcomes measures were: age, sex, cigarette smoking, total score of the ADA diabetes risk-factor questionnaire, family history of diabetes, body mass index, insufficient physical activity, blood pressure, capillary blood glucose, motivation for lifestyle change, counselling activities and triage decisions of the pharmacy team.
RESULTS: During the 5 weeks of spring 2002, 530 pharmacies screened a total of 93,258 persons (33.1% male, mean age 60.9 years +/- 14.1 (SD)). Risk profile: family history of diabetes 26.4%; BMI > or = 25 kg/m(2) 49.3%; low physical activity 27.2%; elevated blood pressure 45.7%. Stratification into risk groups: < 2 risk factors 21.6%; > or = 2 risk factors 71.5%; borderline glycaemia (FG 5.3-6.1 mmol/l, confirmed in a second measurement) 2.5% and hyperglycaemia (FG > or = 6.1 mmol/1 or NFG > or = 11.1 mmol/1) 4.4%. Of all persons screened, 6.4% were referred to a physician and 73.7% got targeted advice with respect to physical activity and/or nutrition based on their specific risk profile.
CONCLUSION: The screening campaign attracted an important part of Swiss German speaking adults (2.4%). The sequential screening could successfully be implemented into pharmacy practice. Of the generally elderly persons screened, 6.9% were detected with suspicion for diabetes type 2 and 71.5% had at least two risk factors. This provided an opportunity to initiate targeted counselling regarding therapeutic lifestyle change.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17004016     DOI: 10.1007/s11096-006-9034-6

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  21 in total

Review 1.  The prevention or delay of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2002-04       Impact factor: 19.112

Review 2.  The transtheoretical model of health behavior change.

Authors:  J O Prochaska; W F Velicer
Journal:  Am J Health Promot       Date:  1997 Sep-Oct

3.  Screening for type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

4.  Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies.

Authors:  Andrea Botomino; Rudolf Bruppacher; Stephan Krähenbühl; Kurt E Hersberger
Journal:  Pharm World Sci       Date:  2007-11-29

5.  The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

Authors:  Trevor J Orchard; Marinella Temprosa; Ronald Goldberg; Steven Haffner; Robert Ratner; Santica Marcovina; Sarah Fowler
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

6.  White coat effect and white coat hypertension in community pharmacy practice.

Authors:  Andrea Botomino; Benedict Martina; Dominique Ruf; Rudolf Bruppacher; Kurt E Hersberger
Journal:  Blood Press Monit       Date:  2005-02       Impact factor: 1.444

7.  Performance of recommended screening tests for undiagnosed diabetes and dysglycemia.

Authors:  D B Rolka; K M Narayan; T J Thompson; D Goldman; J Lindenmayer; K Alich; D Bacall; E M Benjamin; B Lamb; D O Stuart; M M Engelgau
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

8.  Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study.

Authors:  Maria Inês Schmidt; Bruce B Duncan; Alvaro Vigo; James Pankow; Christie M Ballantyne; David Couper; Frederick Brancati; Aaron R Folsom
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

9.  Screening for type 2 diabetes mellitus in adults: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

10.  Effectiveness of diabetes mellitus screening recommendations.

Authors:  Florence J Dallo; Susan C Weller
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

View more
  15 in total

1.  Community-based pharmacies: an opportunity to recruit patients?

Authors:  Isabelle Peytremann-Bridevaux; Julie Bordet; Valérie Santschi; Tinh-Hai Collet; Marc Eggli; Bernard Burnand
Journal:  Int J Public Health       Date:  2012-07-01       Impact factor: 3.380

2.  Pharmacy Intervention to Improve HIV Testing Uptake Using a Comprehensive Health Screening Approach.

Authors:  Natalie D Crawford; Trevano Dean; Alexis V Rivera; Taylor Guffey; Silvia Amesty; Abby Rudolph; Jennifer DeCuir; Crystal M Fuller
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

3.  Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies.

Authors:  Andrea Botomino; Rudolf Bruppacher; Stephan Krähenbühl; Kurt E Hersberger
Journal:  Pharm World Sci       Date:  2007-11-29

4.  Screening and identifying diabetes in optometric practice: a prospective study.

Authors:  Jennifer H Howse; Steve Jones; A Pali S Hungin
Journal:  Br J Gen Pract       Date:  2011-07       Impact factor: 5.386

5.  Preventive counselling for public health in pharmacies in South Germany.

Authors:  Karin Schmiedel; Helmut Schlager; Frank Dörje
Journal:  Int J Clin Pharm       Date:  2012-11-06

6.  Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.

Authors:  Una Ørvim Sølvik; Aslaug Johanne Risøy; Reidun L S Kjome; Sverre Sandberg
Journal:  J Diabetes Sci Technol       Date:  2018-04-05

7.  Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada.

Authors:  Marie-Claude Laliberté; Sylvie Perreault; Nicole Damestoy; Lyne Lalonde
Journal:  BMC Public Health       Date:  2012-03-15       Impact factor: 3.295

Review 8.  Community pharmacy COPD services: what do researchers and policy makers need to know?

Authors:  Michael J Twigg; David J Wright
Journal:  Integr Pharm Res Pract       Date:  2017-02-07

9.  The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting.

Authors:  Andrew Willis; Peter Rivers; Laura J Gray; Melanie Davies; Kamlesh Khunti
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

10.  Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important.

Authors:  Sara S McMillan; Fiona Kelly; Adem Sav; Michelle A King; Jennifer A Whitty; Amanda J Wheeler
Journal:  BMJ Open       Date:  2014-12-08       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.